The Alex and Ronni Show at the bottom of this post featuring Ronni's black eye.
The U.S. Food and Drug Administration (FDA) last week, issued an alert to older people that transfusions of young people's blood as an anti-ageing treatment are “unproven and potentially harmful”.
”The FDA goes on to note that such infusions are known to pose a range of health risks in humans,” reports Ars Technica. “These risks include spreading infectious disease, triggering allergic reactions, and causing lung injuries.
“In some people—particularly those with heart disease—the infusions can also overload the circulatory system, causing swelling and breathing trouble, the agency explains.”
I reported on the goulish “young blood” transfusions two years ago highlighting a private clinic called Ambrosia in Monterey, California, where people could pay $8,000 to have blood plasma from teenagers and young adults pumped into their veins.
Ambrosia's owner, Jesse Karmazin, said then that most participants “see improvement” from a one-time infusion within a month.
Although the FDA did not mention Ambrosia in their warning last week, STATnews reports that
”Karmazin, has yet to report the results of a clinical trial he ran testing the procedure, which involves an off-label use of an approved product. On Tuesday [19 February 2019], however, following the release of the FDA statement, a notice on Ambrosia’s site said it would no longer offer the transfusions.”
Further from Ars Technica:
”The sellers suggest that doses of young plasma can treat conditions ranging from normal aging and memory loss to dementia, Parkinson's disease, multiple sclerosis, Alzheimer's disease, heart disease, or post-traumatic stress disorder, according to the FDA.”
People have been looking for a fountain of youth since at least Alexander the Great without any luck. But a growing number of researchers throughout the world have been working for years to develop treatments to slow the ageing process and extend the human lifespan.
I would be a lot happier if they would concentrate on those diseases of age listed above. As an old woman living with terminal cancer, I agree with Markus Kounalakis writing at Washington Monthly:
”The latest young blood therapy will likely only go to risk-taking well-heeled early adopters and late stagers. Here’s an alternative: Live a happy life, love, practice random acts of kindness, drink in moderation, and don’t smoke. It’s a lot easier than getting stuck with either a needle or a big blood bill.”
What do you think?